Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/09/20243:26PMPR Newswire (Canada)Présence non déclarée d'anchois (poisson) dans des mets préparés et vendus par l'entreprise Maison Thaïlandaise
05/09/20243:20PMPR Newswire (US)THE PROLIFT RIGGING COMPANY OPENS NEW FULL-SERVICE BRANCH IN NORTHERN VIRGINIA
05/09/20243:20PMPR Newswire (US)EREZ ASSET MANAGEMENT OUTLINES SPECIFIC INITIATIVES ITS NOMINEES WILL ADVANCE IF ELECTED TO WHITESTONE REIT BOARDNYSE:WSRWhitestone REIT
05/09/20243:20PMPR Newswire (US)SMIRNOFF ICE AND POP CULTURE ICON KATHY HILTON TOAST TO NEW SMIRNOFF ICE SMASH TEA AHEAD OF TEA SIPPIN' (AND SPILLIN') SEASONLSE:DGEDiageo Plc
05/09/20243:20PMPR Newswire (US)SMIRNOFF ICE AND POP CULTURE ICON KATHY HILTON TOAST TO NEW SMIRNOFF ICE SMASH TEA AHEAD OF TEA SIPPIN' (AND SPILLIN') SEASONNYSE:DEODiageo Plc
05/09/20243:19PMPR Newswire (US)Fathom Holdings Reports First Quarter 2024 ResultsNASDAQ:FTHMFathom Holdings Inc
05/09/20243:17PMPR Newswire (US)Group 1 Automotive Board Approves New Share Repurchase Authorization & Declares Quarterly DividendNYSE:GPIGroup 1 Automotive Inc
05/09/20243:17PMPR Newswire (Canada)Agence des transports : Un constat d'échec du MTQ
05/09/20243:16PMPR Newswire (US)Malai Announces Grand Opening of DC Ice Cream Shop
05/09/20243:15PMPR Newswire (US)OPENLANE Announces Participation in Upcoming Investor ConferenceNYSE:KAROPENLANE Inc
05/09/20243:15PMPR Newswire (US)KEYCORP DECLARES QUARTERLY CASH DIVIDEND ON COMMON SHARES AND PREFERRED STOCKSNYSE:KEY.PRIKeyCorp
05/09/20243:15PMPR Newswire (US)KEYCORP DECLARES QUARTERLY CASH DIVIDEND ON COMMON SHARES AND PREFERRED STOCKSNYSE:KEY.PRJKeyCorp
05/09/20243:15PMPR Newswire (US)Globant to Announce First Quarter 2024 Financial Results on May 16thNYSE:GLOBGlobant SA
05/09/20243:15PMPR Newswire (US)MAIN STREET ANNOUNCES FIRST QUARTER 2024 RESULTSNYSE:MAINMain Street Capital Corp
05/09/20243:15PMPR Newswire (US)Nektar Therapeutics Reports First Quarter 2024 Financial ResultsNASDAQ:NKTRNektar Therapeutics
05/09/20243:15PMPR Newswire (US)Instructure to Present at Upcoming Investor ConferencesNYSE:INSTInstructure Holdings Inc
05/09/20243:15PMPR Newswire (US)Scripps reports Q1 2024 financial resultsNASDAQ:SSPEW Scripps Company
05/09/20243:15PMPR Newswire (US)Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.NYSE:EVHEvolent Health Inc
05/09/20243:15PMPR Newswire (US)Drilling Tools International Corp. Reports 2024 First Quarter ResultsNASDAQ:DTIDrilling Tools International Corporation
05/09/20243:15PMPR Newswire (US)KEYCORP DECLARES QUARTERLY CASH DIVIDEND ON COMMON SHARES AND PREFERRED STOCKSNYSE:KEY.PRKKeyCorp
05/09/20243:15PMPR Newswire (US)Denver's PrideFest Celebrates 50th Anniversary This Summer
05/09/20243:15PMPR Newswire (US)Invesco Ltd. Announces April 30, 2024 Assets Under ManagementNYSE:IVZInvesco Ltd
05/09/20243:15PMPR Newswire (US)CNO Financial Group Announces Results from 2024 Annual Shareholder MeetingNYSE:CNOCNO Financial Group Inc
05/09/20243:15PMPR Newswire (US)Drilling Tools International Corp. Reports 2024 First Quarter ResultsAMEX:SDPISuperior Drilling Products Inc
05/09/20243:15PMPR Newswire (US)KEYCORP DECLARES QUARTERLY CASH DIVIDEND ON COMMON SHARES AND PREFERRED STOCKSNYSE:KEYKeyCorp
05/09/20243:15PMPR Newswire (US)Nelnet Reports First Quarter 2024 ResultsNYSE:NNINelnet Inc
05/09/20243:15PMPR Newswire (US)TriNet Wins Five Stevie Awards for PeopleForce 2023 and People Matter CampaignNYSE:TNETTriNet Group Inc
05/09/20243:14PMPR Newswire (Canada)Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate CancerNASDAQ:FUSNFusion Pharmaceuticals Inc
05/09/20243:14PMPR Newswire (Canada)L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - CSTL.PTSXV:CSTL.PCastlecap Capital Inc
05/09/20243:14PMPR Newswire (US)Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate CancerNASDAQ:FUSNFusion Pharmaceuticals Inc